| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
6,220,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0 - $0 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Lantern Pharma is a clinical stage biotechnology company. Co.'s drug candidates are: LP-100, which exploits cancer cells' deficiency in DNA repair mechanisms; LP-300, which is a cysteine-modifying molecular entity that works to modulate multiple cellular pathways simultaneously and is a potential combination agent for targeted indications in non-small cell lung cancer; LP-184, which is a small molecule that preferentially damages DNA in cancer cells that overexpress certain biomarkers or that harbor mutations in DNA repair pathways; and LP-284, which has anti-tumor activities in a variety of hematological cancers including lymphoma, multiple myeloma, and leukemia.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
315,700 |
315,700 |
315,700 |
1,072,174 |
| Total Sell Value |
$1,000,580 |
$1,000,580 |
$1,000,580 |
$4,226,030 |
| Total People Sold |
2 |
2 |
2 |
2 |
| Total Sell Transactions |
14 |
14 |
14 |
28 |
| End Date |
2025-03-30 |
2024-12-27 |
2024-06-28 |
2023-06-29 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Bp Directors, Lp |
10% Owner |
– – • |
2025-06-13 |
4 |
S |
$3.09 |
$123,600 |
I/I |
(40,000) |
114,272 |
|
- |
|
| Bios Advisors Gp, Llc |
10% Owner |
– – • |
2025-06-13 |
4 |
S |
$3.09 |
$123,600 |
I/I |
(40,000) |
114,272 |
|
- |
|
| Bp Directors, Lp |
10% Owner |
– – • |
2025-06-12 |
4 |
S |
$3.38 |
$204,987 |
I/I |
(60,647) |
118,626 |
|
- |
|
| Bios Advisors Gp, Llc |
10% Owner |
– – • |
2025-06-12 |
4 |
S |
$3.38 |
$204,987 |
I/I |
(60,647) |
118,626 |
|
- |
|
| Bp Directors, Lp |
10% Owner |
– – • |
2025-06-11 |
4 |
S |
$3.40 |
$3,230 |
I/I |
(950) |
125,227 |
|
- |
|
| Bios Advisors Gp, Llc |
10% Owner |
– – • |
2025-06-11 |
4 |
S |
$3.40 |
$3,230 |
I/I |
(950) |
125,227 |
|
- |
|
| Bp Directors, Lp |
10% Owner |
– – • |
2025-06-10 |
4 |
S |
$3.40 |
$54 |
I/I |
(16) |
125,330 |
|
- |
|
| Bios Advisors Gp, Llc |
10% Owner |
– – • |
2025-06-10 |
4 |
S |
$3.40 |
$54 |
I/I |
(16) |
125,330 |
|
- |
|
| Bp Directors, Lp |
10% Owner |
– – • |
2025-05-29 |
4 |
S |
$3.03 |
$61,206 |
I/I |
(20,200) |
125,332 |
|
- |
|
| Bios Advisors Gp, Llc |
10% Owner |
– – • |
2025-05-29 |
4 |
S |
$3.03 |
$61,206 |
I/I |
(20,200) |
125,332 |
|
- |
|
| Bp Directors, Lp |
10% Owner |
– – • |
2025-05-28 |
4 |
S |
$2.87 |
$43,050 |
I/I |
(15,000) |
127,531 |
|
- |
|
| Bios Advisors Gp, Llc |
10% Owner |
– – • |
2025-05-28 |
4 |
S |
$2.87 |
$43,050 |
I/I |
(15,000) |
127,531 |
|
- |
|
| Bp Directors, Lp |
10% Owner |
– – • |
2025-05-27 |
4 |
S |
$3.05 |
$64,163 |
I/I |
(21,037) |
129,163 |
|
- |
|
| Bios Advisors Gp, Llc |
10% Owner |
– – • |
2025-05-27 |
4 |
S |
$3.05 |
$64,163 |
I/I |
(21,037) |
129,163 |
|
- |
|
| Keyser D Jeffrey |
Director |
– • – |
2024-07-24 |
4 |
OE |
$3.13 |
$11,994 |
D/D |
3,832 |
0 |
|
- |
|
| Bp Directors, Lp |
10% Owner |
– – • |
2024-05-24 |
4 |
S |
$6.33 |
$126,600 |
I/I |
(20,000) |
131,453 |
|
- |
|
| Bios Advisors Gp, Llc |
10% Owner |
– – • |
2024-05-24 |
4 |
S |
$6.33 |
$126,600 |
I/I |
(20,000) |
131,453 |
|
- |
|
| Bp Directors, Lp |
10% Owner |
– – • |
2024-05-23 |
4 |
S |
$6.25 |
$62,500 |
I/I |
(10,000) |
135,706 |
|
- |
|
| Bios Advisors Gp, Llc |
10% Owner |
– – • |
2024-05-23 |
4 |
S |
$6.25 |
$62,500 |
I/I |
(10,000) |
135,706 |
|
- |
|
| Bp Directors, Lp |
10% Owner |
– – • |
2024-02-29 |
4 |
S |
$4.87 |
$95,954 |
I/I |
(19,703) |
137,832 |
|
- |
|
| Bios Advisors Gp, Llc |
10% Owner |
– – • |
2024-02-29 |
4 |
S |
$4.87 |
$95,954 |
I/I |
(19,703) |
137,832 |
|
- |
|
| Bp Directors, Lp |
10% Owner |
– – • |
2024-02-28 |
4 |
S |
$4.85 |
$360,340 |
I/I |
(74,297) |
142,017 |
|
- |
|
| Bios Advisors Gp, Llc |
10% Owner |
– – • |
2024-02-28 |
4 |
S |
$4.85 |
$360,340 |
I/I |
(74,297) |
142,017 |
|
- |
|
| Bp Directors, Lp |
10% Owner |
– – • |
2024-02-27 |
4 |
S |
$4.40 |
$220,000 |
I/I |
(50,000) |
157,797 |
|
- |
|
| Bios Advisors Gp, Llc |
10% Owner |
– – • |
2024-02-27 |
4 |
S |
$4.40 |
$220,000 |
I/I |
(50,000) |
157,797 |
|
- |
|
48 Records found
|
|
Page 1 of 2 |
|
|
